Total Valuation
Glucose Health has a market cap or net worth of $8.06M. The enterprise value is $8.37M.
Market Cap$8.06M
Enterprise Value$8.37M
Share Statistics
Glucose Health has 26,875,938 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding26,875,938
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Glucose Health’s return on equity (ROE) is -1.57 and return on invested capital (ROIC) is -136.11%.
Return on Equity (ROE)-1.57
Return on Assets (ROA)-1.32
Return on Invested Capital (ROIC)-136.11%
Return on Capital Employed (ROCE)-1.36
Revenue Per Employee113.55K
Profits Per Employee-76.90K
Employee Count3
Asset Turnover1.95
Inventory Turnover2.00
Valuation Ratios
The current PE Ratio of Glucose Health is ―. Glucose Health’s PEG ratio is 0.39.
PE Ratio―
PS Ratio11.16
PB Ratio25.90
Price to Fair Value25.90
Price to FCF-241.42
Price to Operating Cash Flow-50.60
PEG Ratio0.39
Income Statement
In the last 12 months, Glucose Health had revenue of 340.66K and earned -230.70K in profits. Earnings per share was -0.02.
Revenue340.66K
Gross Profit119.22K
Operating Income-199.80K
Pretax Income-230.70K
Net Income-230.70K
EBITDA-197.16K
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -170.61K and capital expenditures -4.00, giving a free cash flow of -170.62K billion.
Operating Cash Flow-170.61K
Free Cash Flow-170.62K
Free Cash Flow per Share>-0.01
Dividends & Yields
Glucose Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.64
52-Week Price Change226.09%
50-Day Moving Average0.35
200-Day Moving Average0.33
Relative Strength Index (RSI)42.33
Average Volume (3m)12.83K
Important Dates
Glucose Health upcoming earnings date is Aug 7, 2023, TBA (Not Confirmed).
Last Earnings DateMay 17, 2023
Next Earnings DateAug 7, 2023
Ex-Dividend Date―
Financial Position
Glucose Health as a current ratio of 5.64, with Debt / Equity ratio of 5.78%
Current Ratio5.64
Quick Ratio1.64
Debt to Market Cap0.00
Net Debt to EBITDA0.16
Interest Coverage Ratio-5.46
Taxes
In the past 12 months, Glucose Health has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Glucose Health EV to EBITDA ratio is -19.13, with an EV/FCF ratio of -239.47.
EV to Sales11.07
EV to EBITDA-19.13
EV to Free Cash Flow-239.47
EV to Operating Cash Flow-239.46
Balance Sheet
Glucose Health has $35.20K in cash and marketable securities with $4.25K in debt, giving a net cash position of $30.95K billion.
Cash & Marketable Securities$35.20K
Total Debt$4.25K
Net Cash$30.95K
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 20.89%, with operating margin of -58.65%, and net profit margin of -67.72%.
Gross Margin20.89%
Operating Margin-58.65%
Pretax Margin-67.72%
Net Profit Margin-67.72%
EBITDA Margin-57.88%
EBIT Margin-58.65%
Analyst Forecast
The average price target for Glucose Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-1.88%
EPS Growth Forecast12.20%